American Society of Hirudotherapy

Leech therapeutic applications

Research article published in Indian journal of pharmaceutical sciences (2013)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsDrug DevelopmentSafety & Infection ControlAbdualkader A et al. · Indian journal of pharmaceutical sciences, 2013

Abstract

Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding to systemic ailments, such as skin diseases, nervous system abnormalities, urinary and reproductive system problems, inflammation, and dental problems. Recently, extensive researches on leech saliva unveiled the presence of a variety of bioactive peptides and proteins involving antithrombin (hirudin, bufrudin), antiplatelet (calin, saratin), factor Xa inhibitors (lefaxin), antibacterial (theromacin, theromyzin) and others. Consequently, leech has made a comeback as a new remedy for many chronic and life-threatening abnormalities, such as cardiovascular problems, cancer, metastasis, and infectious diseases. In the 20(th) century, leech therapy has established itself in plastic and microsurgery as a protective tool against venous congestion and served to salvage the replanted digits and flaps. Many clinics for plastic surgery all over the world started to use leeches for cosmetic purposes. Despite the efficacious properties of leech therapy, the safety, and complications of leeching are still controversial.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview

Summary

Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization.

Why This Matters for Hirudotherapy

This review article surveys the historical and contemporary therapeutic applications of leeches, cataloguing bioactive salivary compounds including antithrombins (hirudin, bufrudin), antiplatelet agents (calin, saratin), factor Xa inhibitors (lefaxin), and antimicrobial peptides (theromacin, theromyzin), alongside established clinical uses in plastic and microsurgery for venous congestion. It is directly relevant to ASH's domain as a broad overview of the leech salivary secretome and its translational potential across cardiovascular disease, oncology, and infectious diseases. The review provides useful background on the diversity of bioactive molecules in leech saliva and the historical trajectory of hirudotherapy, making it a reasonable introductory reference. However, as a narrative review, it presents no new primary data, quantitative analysis, or systematic appraisal of evidence, and its claims regarding emerging applications remain speculative pending clinical validation; the abstract also notes that safety and complication profiles remain controversial.

Citation

Leech therapeutic applications.

Abdualkader A et al. · Indian journal of pharmaceutical sciences, 2013

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.